Functional biomimetic nanoparticles for drug delivery and theranostic applications in cancer treatment

67Citations
Citations of this article
92Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Nanotechnology has been extensively utilized in the design and development of powerful strategies for drug delivery and cancer theranostic. Nanoplatforms as a drug delivery system have many advantages such as in vivo imaging, combined drug delivery, extended circulation time, and systemic controlled release. The functional biomimetic drug delivery could be realized by incorporating stimuli-responsive (pH, temperature, redox potential, etc.) properties into the nanocarrier system, allowing them to bypass biological barriers and arrive at the targeted area. In this review, we discuss the role of internal stimuli-responsive nanocarrier system for imaging and drug delivery in cancer therapy. The development of internal stimuli-responsive nanoparticles is highlighted for precision drug delivery applications, with a particular focus on in vivo imaging, drug release performance, and therapeutic benefits.

Cite

CITATION STYLE

APA

Li, L., Wang, J., Kong, H., Zeng, Y., & Liu, G. (2018, December 31). Functional biomimetic nanoparticles for drug delivery and theranostic applications in cancer treatment. Science and Technology of Advanced Materials. Taylor and Francis Ltd. https://doi.org/10.1080/14686996.2018.1528850

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free